Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software - An Objective EEG/ERP Brain Health Assessment

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Software
General Health
Radiology
Professional Services
Venture Capital
Medical Devices
Technology
Health Technology
Biotechnology
Neurology
FDA
Health
Cognitive Function Neuroimaging (cfNI) Software

More Like This

PR Newswire associated0

Cumulus Neuroscience Publishes Data Validating a Scalable Measurement of Neuroplasticity Using Low-Burden Dry Sensor EEG

PR Newswire associated0

Cumulus Neuroscience Announces Publication in Frontiers in Digital Health Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home Cognitive and EEG Assessment in People Living with Mild Alzheimer's Disease Dementia

PR Newswire associated0

Cumulus Neuroscience Presents Data at ECNP 2023 Annual Meeting

PR Newswire associated0

Cumulus Neuroscience Presents Data at the International Society for CNS Clinical Trials and Methodology Autumn Conference and the 38th European College of Neuropsychopharmacology Congress

PR Newswire associated0

Cumulus Neuroscience Presents Data at AAIC 2024 Annual Meeting and Technology and Dementia Preconference

PR Newswire associated0

3-minute EEG Test Reliably Detects Memory Impairment, Enabling Earlier Alzheimer's Diagnosis

PR Newswire associated0

Positrigo Secures CE Mark in Europe for its Pioneering Dedicated Brain PET System

PR Newswire associated0

Cumulus Neuroscience and Muse by Interaxon Bring Validated At-Home Sleep EEG to CNS Clinical Trials

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us